Mycobacteria within its intracellular niche: Survival of the pathogen or its host?

Current Science

Volumn 86, Issue 1, 2004, Pages 103-110

  Basu, Joyoti ^a  

^a BOSE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM;

EID: 4444350518     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. Flynn, J. L. and Chan, J., Immunology of tuberculosis. Annu. Rev. Immunol., 2001, 19, 93-129.
2. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature, 1998, 392, 245-252.
3. Ting, L. M., Kim, A. C., Cattamanchi, A. and Ernst, J. D., Mycobacterium tuberculosis inhibits IFN-γ transcriptional responses without inhibiting activation of STAT1. J. Immunol., 1999, 163, 3898-3906.
4. Trinchieri, G., Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol., 1998, 70, 83-243.
5. Cooper, A. M., Magram, J. Ferrante, J. and Orme, I. M., Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med., 1997, 186, 39-45.
6. Doffinger, R., Altare, F. and Casanova, J. L., Genetic heterogeneity of Mendelian susceptibility to mycobacterial infection. Microbes Infect., 2000, 2, 1553-1557.
7. Altare, F., Jouanguy, E., Lamhamedi, S., Doffinger, R., Fischer, A. and Casanova, J. L., Mendelian susceptibility to mycobacterial infection in man. Curr. Opin. Immunol., 1998, 10, 413-417.
8. Nau, G. J., Richmond, J. F. L., Schlesinger, A., Jennings, E. G., Lander, E. S. and Young, R. A., Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. USA, 2002, 99, 1503-1508.
9. Tailleux, et al., DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J. Exp. Med., 2003, 197, 121-127.
10. Schlesinger, L. Z., Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol., 1993, 150, 2920-2930.
11. Maeda, N. et al., The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J. Biol. Chem., 2003, 278, 5513-5516.
12. Chatterjee, D. and Khoo, K. H., Structural features of lipoarabinomannan from Mycobacterium bovis BCG: Determination of molecular mass by laser desorption mass spectrometry. Glycobiology, 1998, 8, 113-120.
13. Venisse, A., Berjeaud, J. M., Chaurand, P., Gilleron, M. and Puzo, G., Structural features of lipoarabinomannan from Mycobacterium bovis BCG: Determination of molecular mass by laser desorption mass spectrometry. J. Biol. Chem., 1993, 268, 12401-12411.
14. Chatterjee, D., Khoo, K. H., McNeil, M. R., Dell, A., Morris, H. R. and Brennan, P. J., Structural definition of the non-reducing termini of mannose-capped LAM from Mycobacterium tuberculosis through selective enzymatic degradation and fast atom bombardment-mass spectrometry. Glycobiology, 1993, 3, 497-500.
15. Prinzis, S., Chatterjee, D. and Brennan, P. J., Structure and antigenicity of lipoarabinomannan from Mycobacterium bovis BCG. Gen. Microbiol., 1993, 139, 2649-2658.
16. Gilleron, M., Himoudi, N., Adam, O., Constant, P., Venisse, A., Riviere, M. and Puzo, G., Mycobacterium smegmatis phosphoinositols-glyceroarabinomannans. Structure and localization of alkali-labile and alkali-stable phosphoinositides. J. Biol. Chem., 1997, 272, 117-124.
17. Khoo, K. H., Dell, A., Morris, H. R., Brennan, P. J. and Chatterjee, D., Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growing strains of Mycobacterium. J. Biol. Chem., 1995, 270, 12380-12389.
18. Nigou, J., Zelle, Rieser, C., Gilleron, M., Thurnher, M. and Puzo, G., Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J. Immunol., 2001, 166, 7477-7485.
19. Geijtenbeek, T. B., Van Vliet, S. J., Koppel, E. A., Sanchez-Hernandez, M., Vanden-Broucke-Grauls, C. M., Appelmelk, B. and van Kooyk, Y., Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med., 2003, 197, 7-17.
20. van Kooyk, Y., Appelmelk, B. and Geijtenbeek, T. B. H., A fatal attraction: Mycobacterium tuberculosis and HIV-1 target DC-SIGN to escape immune surveillance. Trends Mol. Med., 2003, 9, 153-159.
21. Knutson, K. L., Hmama, Z., Herrea-Velit, P., Rochford, R. and Reiner, N. E., Lipoarabinomannan of Mycobacterium tuberculosis promotes protein tyrosine dephosphorylation and inhibition of mitogen-activated protein kinase in human mononuclear phagocytes. Role of the Src homology 2 containing tyrosine phosphatase 1. J. Biol. Chem., 1998, 273, 645-652.
22. Johansson, U., Ivanyi, J. and Londei, M., Inhibition of IL-12 production in human dendritic cells matured in the presence of Bacillus Calmette-Guerin or lipoarabinomannan. Immunol. Lett., 2001, 77, 63-66.
23. Nigou, J., Gilleron, M., Brando, T., Vercellone, A. and Puzo, G., Structural definition of arabinomannans from Mycobacterium bovis BCG. Glycoconj. J., 1999, 16, 257-264.
24. Rojas, M., Barrera, L. F. and Garcia, L. F., Induction of apoptosis in murine macrophages by Mycobacterium tuberculosis is reactive oxygen intermediates-independent. Biochem. Biophys. Res. Commun., 1998, 247, 436-442.
25. Rojas, M., Olivier, M., Gras, P., Barrera, L. F., Puzo, G. and Garcia, L. F., TNF-α and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. J. Immunol., 1999, 162, 6122-6131.
26. Rojas, M., Barrera, L. F., Puzo, G. and Garcia, L. F., Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages: role of nitric oxide and mycobacterial products. J. Immunol., 1997, 159, 1352-1361.
27. Maiti, D., Bhattacharyya, A. and Basu, J., Lipoarabinomannan from Mycobacterium tuberculosis promotes macrophage survival by phosphorylating Bad through a phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem., 2001, 276, 329-333.
28. Datta, S. R., Brunet, A. and Greenberg, M. E., Cellular survival: a play in three Akts. Genes Dev., 1999, 13, 2905-2927.
29. 2+-dependent cell signaling. J. Infect. Dis., 2000, 181, 240-251.
30. 2+-stimulated adenylyl cyclases in LTP and memory formation. Int. J. Dev. Eurosci., 2001, 19, 387-394.
31. Horvai, A. E. et al., Nuclear integration of JAK/STAT and Ras/ AP-1 signaling by CBP and p300. Proc. Natl. Acad. Sci. USA, 1997, 94, 1074-1079.
32. Chin, Y. E., Kitagawa, M., Kuida, K., Flavell, R. A. and Fu, X. Y., Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol. Cell. Biol., 1997, 17, 5328-5337.
33. Fratti, R. A., Chaua, J., Vergne, I. and Deretic, V., Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc. Natl. Acad. Sci. USA, 2003, 100, 5437-5442.
34. Rhoades, E., Hsu, F.-F., Torrelles, J. B., Turk, J., Chatterjee, D. and Russell, D. G., Identification and rnacrophage-activating activity of glycolipids released from intracellular Mycobacterium bovis BCG. Mol. Microbiol., 2003, 48, 875-888.
35. Camacho, L. R., Ensergueix, D., Perez, E., Gicquel, B. and Guilhot, C., Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol. Microbiol., 1999, 34, 257-267.
36. Cox, J. S., Chen, B., McNeil, M. and Jacobs, W. R., Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature, 1999, 402, 79-83.
37. Beatty, W. B., Rhoades, E. R., Ullrich, H. J., Chatterjee, D. and Russell, D. G., Trafficking and release of mycobacterial lipids from infected macrophages. Traffic, 2000, 1, 235-247.
38. Beatty, W. L., Ullrich, H. J. and Russell, D. G., Mycobacterial surface moieties are released from infected macrophages by a constitutive exocytic event. Eur. J. Cell Biol., 2001, 80, 31-40.
39. Heldwein, K. A. and Fenton, M., The role of Toll-like receptors in immunity against mycobacterial infection. Microbes. Infect., 2002, 4, 937-944.
40. Takeda, K. and Akira, S., Toll receptors and pathogen resistance. Cell. Microbiol., 2003, 5, 143-153.
41. Bulut, Y., Faure, E., Thomas, L., Equils, O. and Arditi, M., Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J. Immunol., 2001, 167, 987-994.
42. Fitzgerald, K. A. et al., Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature, 2001, 413, 78-83.
43. Horng, T., Barton, G. M. and Medzhitov, R., TIRAP: an adapter molecule in the Toll signaling pathway. Nature Immunol., 2001, 2, 835-841.
44. Jones, B. W., Heldwein, K. A., Means, T. K., Saukoven, S. and Fenton, M. J., Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages. Ann. Rheum. Dis., 2001, 60, Suppl. 3: iii, 6-12.
45. Means, T. K., Lien, E., Yoshimura, A., Wang, S., Golenbock, D. T. and Fenton, M. J., The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J. Immunol., 1999a, 163, 6748-6755.
46. Brightbill, H. D. et al., Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science, 1999, 285, 732-736.
47. Means, T. K., Wang, S., Lien, E., Yoshimura, A., Golenbock, D. T. and Fenton, M. J., Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol., 1999b, 163, 3920-3927.
48. Lien, E. et al., Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem., 1999, 274, 33419-33425.
49. Thoma-Uszynki, S. et al., Induction of direct antimicrobial activity through mammalian Toll-like receptors. Science, 2001, 292, 1544-1547.
50. Aliprantis, A. O. et al., Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science, 1999, 285, 736-739.
51. Means, T. K. et al., Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J. Immunol., 2001, 166, 4074-4082.
52. Noss, E. H., Rai, R. K., Sellati, T. J., Radolf, J. D. B., Golenbock, D. T., Boom, W. H. and Harding, C. V., Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J. Immunol., 2001, 176, 910-918.
53. Pai, R. K., Convery, M., Hamilton, T. A., Boom, W. H. and Harding, C. V., Inhibition of IFN-γ-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. J. Immunol., 171, 175-184.
54. Wang, T., Lafuse, W. and Zwilling, B. S., Regulation of Toll-like receptor 2 expression by macrophages following Mycobacterium avium infection. J. Immunol., 2000, 165, 6308-6313.
55. Reiling, R., Holscher, C., Fehrenbach, A., Kroger, S., Kirsching, C. J., Goyert, S. and Ehlers, S., Toll like receptor 2 (TLR2)- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J. Immunol., 2002, 169, 3480-3484.
56. Cobb, M. H., MAP kinase pathways. Progr. Biophys. Mol. Biol., 1999, 71, 479-500.
57. Martin-Blanco, E., p38 MAPK signalling cascades: ancient roles and new functions. Bioessays, 2000, 22, 637-645.
58. Chen, C., Chen, Y. H. and Lin, W. W., Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages. Immunology, 1999, 97, 124-129.
59. Chan, E. D., Morris, K. R., Belisle, J. T., Hill, P., Remigio, L. K., Brennan, P. J. and Riches, D. W., Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-κB signaling pathways. Infect. Immun., 2001, 69, 2001-2010.
60. Reiling, N., Blumenthal, A., Flad, H. D., Ernst, M. and Ehlers, S., Mycobacteria-induced TNF-α and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity. J. Immunol., 2001, 167, 3339-3345.
61. Bhattacharyya, A., Pathak, S., Kundu, M. and Basu, J., Mitogen-activated protein kinases regulate Mycobacterium avium-induced tumor necrosis factor-α release from macrophages. FEMS Immunol. Med. Microbiol., 2002, 34, 73-80.
62. Roach, S. K. and Schorej, J. S., Differential regulation of the mitogen-activated protein kinases by pathogenic and nonpathogenic mycobacteria. Infect. Immun., 2002, 70, 3040-3052.
63. Tse, H. M., Josephy, S. I., Chan, E. D., Fouts, D. and Cooper, A. M., Activation of the mitogen-activated protein kinase signaling pathway is instrumental in determining the ability of Mycobacterium avium to grow in murine macrophages. J. Immunol., 2002, 168, 825-833.
64. 2+ signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages. J. Exp. Med., 2000, 191, 287-302.
65. Mendez-Samperio, P., Plama, J. and Vazquez, A., Roles of intracellular calcium and NF-κB in the Bacillus Calmette-Guerin-induced secretion of interleukin-8 from human monocytes. Cell. Immunol., 2001, 211, 113-122.
66. Sugawara, I., Mizuno, S., Yamada, H., Matsumoto, M. and Akira, S., Disruption of nuclear factor-interleukin-6, a transcription factor, results in severe mycobacterial infection. Am. J. Pathol., 2001, 158, 361-366.
67. Jones, B. W., Means, T. K., Heldwein, K. A., Keen, M. A., Holl, P. J., Belisel, J. T. and Fenton, M. J., Different Toll-like receptor agonists induce distinct macrophage responses. J. Leukoc. Biol., 2001, 69, 1036-1044.
68. Fratazzi, C., Arbeit, R. D., Carini, C. and Remold, H. G., Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J. Immunol., 1997, 158, 4320-4327.
69. Molloy, A., Laochumroonvorapong, P. and Kaplan, G., Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin. J. Exp. Med., 1994, 180, 1499-1509.
70. Oddo, M., Renno, T., Attinger, A., Bakker, T., MacDonald, H. R. and Meylan, P. R. A., Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J. Immunol., 1998, 160, 5448-5454.
71. Riendeau, C. J. and Kornfeld, H., THP-1 cell apoptosis in response to mycobacterial infection. Infect. Immun., 2003, 71, 254-259.
72. Bhattacharyya, A., Pathak, S., Basak, C., Law, S., Kundu, M. and Basu, J., Execution of macrophage apoptosis by Mycobacterium avium through apoptosis signal-regulating kinase 1/p38 mitogen-activated protein kinase signaling and caspase 8 activation. J. Biol. Chem., 2003, 278, 26517-26525.
73. Balcewicz-Sablinska, M. K., Keane, J., Kornfeld, H. and Remold, H. G., Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-α. J. Immunol., 1998, 161, 2636-2641.
74. Duan, L., Gan, H., Golan, D. E. and Remold, H. G., Critical role of mitochondrial damage in determining outcome of macrophage infection with Mycobacterium tuberculosis. J. Immunol., 2002, 169, 5181-5187.
75. Clemens, D. L., Lee, B. Y. and Horwitz, M. A., Mycobacterium tuberculosis and Legionella pneumophila phagosornes exhibit arrested maturation despite acquisition of Rab7. Infect. Immun., 2000, 68, 5154-5166.
76. Sturgill-Koszycki, S., Schaible, U. E. and Russell, D. G., Mycobacterium-containing phagosomes are accessible to early endosomes and reflect a transitional state in normal phagosome biogenesis. EMBO J., 1996, 15, 6960-6968.
77. Crowle, A. J., Dahl, R., Ross, E. and May, M. H., Evidence that vesicles containing living virulent M. tuberculosis or M. avium in cultured human macrophages are not acidic. Infect. Immun., 1991, 59, 1823-1831.
78. Sturgill-Koszycki, S. et al., Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science, 1994, 263, 678-681.
79. Via, L. E., Deretic, D., Ulmer, R. J., Hibler, N. S., Huber, L. A. and Deretic, V., Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7. J. Biol. Chem., 1997, 272, 13326-13331.
80. Clemens, D. L., Lee, B. Y. and Horwitz, M. A., Deviant expression of Rab5 on phagosomes containing the intracellular pathogens Mycobacterium tuberculosis and Legionella pneumophila is associated with altered phagosomal fate. Infect. Immun., 2000, 68, 2671-2684.
81. Beatty, W. L., Rhoades, E. R., Hsu, D. K., Liu, F.-T. and Russell, D. G., Association of a macrophage galactoside-binding protein with Mycobacterium-containing phagosomes. Cell. Microbiol., 2002, 4, 167-176.
82. Malik, Z. A., Iyer, S. S. and Kusner, D. J., Mycobacterium tuberculosis phagosomes exhibit altered calmodulin-dependent signal transduction: contribution to inhibition of phagosome-lysosome fusion and intracellular survival in human macrophages. J. Immunol., 2001, 166, 3392-3401.
83. 2+ signaling and phagosome maturation in human macrophages via specific inhibition of sphingosine kinase. J. Immunol., 2003, 170, 2811-2815.
84. Ferrari, G., Langen, H., Naito, M. and Pieters, J., A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell, 1999, 97, 435-447.
85. Gatfield, J. and Pieters, J., Essential role for cholesterol in entry of mycobacteria into macrophages. Science, 2000, 288, 1647-1650.
86. Russell, D. G., Dant, J. and Sturgill-Koszycki, S., Mycobacterium avium- and Mycobacterium tuberculosis-containing vacuoles are dynamic, fusion-competent vesicles that are accessible to glycosphingolipids from the host cell plasmalemma. J. Immunol., 1996, 156, 4764-4773.
87. Pancholi, P., Mirza, A., Bhardwaj, N. and Steinman, R. M., Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages. Science, 1993, 260, 984-986.
88. Wadee, A. A., Kuschke, R. H. and Dooms, T. G., The inhibitory effects of Mycobacterium tuberculosis on MHC class II expression by monocytes activated with riminophenazines and phagocyte stimulants. Clin. Exp. Immunol., 1995, 100, 434-439.
89. Wojciechowski, C. W., DeSanctis, J., Skamene, E. and Radzioch, D., Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guerin involves class II transactivator and depends on the Nramp1 gene. J. Immunol., 1999, 163, 2688-2696.
90. Stenger, S., Niazi, K. R. and Modlin, R. L., Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis. J. Immunol., 1998, 161, 3582-3588.
91. Noss, E. H., Harding, C. V. and Boom, W. H., Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. Cell Immunol., 2000, 201, 63-74.
92. DeLerma Barbaro, A. et al., Block of Stat-1 activation in macroI phages phagocytosing bacteria causes reduced transcription of CIITA and consequent impaired antigen presentation. Eur. J. Immunol., 2002, 32, 1309-1318.
93. Jiao, X. et al., Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J. Immunol., 2002, 168, 1294-1301.
94. Bodnar, K. A., Serbina, N. V. and Flynn, J. L., Fate of Mycobacterium tuberculosis within murine dendritic cells. Infect. Immun., 2001, 69, 800-809.
95. Schaible, U. E., Agens, K., Fischer, K., Collins, H. L. and Kaufmann, S. H., Intersection of group I CD1 molecules and mycobacteria in different intracellular compartments of dendritic cells. J. Immunol., 2000, 164, 4843-4852.
96. Greenwell-Wild, T., Vazquez, N., Sim, D., Schito, M., Chatterjee, D., Orenstein, J. M. and Wahl, S. M., Mycobacterium avium infection and modulation of human macrophage gene expression. J. Immunol., 2002, 169, 6286-6297.